Baird Financial Group
GRNA

Baird Financial Group’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Baird Financial Group’s Portfolio GRNA Stock Details GRNA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$417K Sell
2022
Q4 		$1.83M Sell
2022
Q3 		$6.63M Buy